The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion

Ricardo Cáceda, Elisabeth B. Binder, Becky Kinkead, Charles Nemeroff

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The neuropeptide neurotensin (NT) is closely associated with dopaminergic and glutamatergic systems in the rat brain. Central injection of NT into the nucleus accumbens (NAcc) or peripheral administration of NT receptor agonists, reduces many of the behavioral effects of psychostimulants. However, the role of endogenous NT in the behavioral effects of psychostimulants (e.g. DA agonists and NMDA receptor antagonists) remains unclear. Using a NTR antagonist, SR142948A, the current studies were designed to examine the role of endogenous NT in DA receptor agonist- and NMDA receptor antagonist-induced disruption of prepulse inhibition of the acoustic startle response (PPI), locomotor hyperactivity and brain-region specific . c-fos mRNA expression. Adult male rats received a single i.p. injection of SR142948A or vehicle followed by . d-amphetamine, apomorphine or dizocilpine challenge. SR142948A had no effect on baseline PPI, but dose-dependently attenuated . d-amphetamine- and dizocilpine-induced PPI disruption and enhanced apomorphine-induced PPI disruption. SR142948A did not significantly affect either baseline locomotor activity or stimulant-induced hyperlocomotion. Systemic SR142948A administration prevented . c-fos mRNA induction in mesolimbic terminal fields (prefrontal cortex, lateral septum, NAcc, ventral subiculum) induced by all three psychostimulants implicating the VTA as the site for NT modulation of stimulant-induced PPI disruption. Further characterization of the NT system may be valuable to find clinical useful compounds for schizophrenia and drug addiction.

Original languageEnglish
Pages (from-to)88-95
Number of pages8
JournalSchizophrenia Research
Volume136
Issue number1-3
DOIs
StatePublished - Apr 1 2012

Fingerprint

Neurotensin
Locomotion
Dextroamphetamine
Dizocilpine Maleate
Apomorphine
Nucleus Accumbens
N-Methyl-D-Aspartate Receptors
Startle Reflex
Neurotensin Receptors
Septal Nuclei
Messenger RNA
Injections
Brain
Prefrontal Cortex
Neuropeptides
Acoustics
Substance-Related Disorders
Prepulse Inhibition
Hippocampus
Schizophrenia

Keywords

  • Apomorphine
  • C-fos
  • D-amphetamine
  • Dizocilpine
  • Locomotion
  • Neurotensin
  • Prepulse inhibition

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion. / Cáceda, Ricardo; Binder, Elisabeth B.; Kinkead, Becky; Nemeroff, Charles.

In: Schizophrenia Research, Vol. 136, No. 1-3, 01.04.2012, p. 88-95.

Research output: Contribution to journalArticle

Cáceda, Ricardo ; Binder, Elisabeth B. ; Kinkead, Becky ; Nemeroff, Charles. / The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion. In: Schizophrenia Research. 2012 ; Vol. 136, No. 1-3. pp. 88-95.
@article{02d8510fc60149bba35fa99c8576e694,
title = "The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion",
abstract = "The neuropeptide neurotensin (NT) is closely associated with dopaminergic and glutamatergic systems in the rat brain. Central injection of NT into the nucleus accumbens (NAcc) or peripheral administration of NT receptor agonists, reduces many of the behavioral effects of psychostimulants. However, the role of endogenous NT in the behavioral effects of psychostimulants (e.g. DA agonists and NMDA receptor antagonists) remains unclear. Using a NTR antagonist, SR142948A, the current studies were designed to examine the role of endogenous NT in DA receptor agonist- and NMDA receptor antagonist-induced disruption of prepulse inhibition of the acoustic startle response (PPI), locomotor hyperactivity and brain-region specific . c-fos mRNA expression. Adult male rats received a single i.p. injection of SR142948A or vehicle followed by . d-amphetamine, apomorphine or dizocilpine challenge. SR142948A had no effect on baseline PPI, but dose-dependently attenuated . d-amphetamine- and dizocilpine-induced PPI disruption and enhanced apomorphine-induced PPI disruption. SR142948A did not significantly affect either baseline locomotor activity or stimulant-induced hyperlocomotion. Systemic SR142948A administration prevented . c-fos mRNA induction in mesolimbic terminal fields (prefrontal cortex, lateral septum, NAcc, ventral subiculum) induced by all three psychostimulants implicating the VTA as the site for NT modulation of stimulant-induced PPI disruption. Further characterization of the NT system may be valuable to find clinical useful compounds for schizophrenia and drug addiction.",
keywords = "Apomorphine, C-fos, D-amphetamine, Dizocilpine, Locomotion, Neurotensin, Prepulse inhibition",
author = "Ricardo C{\'a}ceda and Binder, {Elisabeth B.} and Becky Kinkead and Charles Nemeroff",
year = "2012",
month = "4",
day = "1",
doi = "10.1016/j.schres.2011.10.013",
language = "English",
volume = "136",
pages = "88--95",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion

AU - Cáceda, Ricardo

AU - Binder, Elisabeth B.

AU - Kinkead, Becky

AU - Nemeroff, Charles

PY - 2012/4/1

Y1 - 2012/4/1

N2 - The neuropeptide neurotensin (NT) is closely associated with dopaminergic and glutamatergic systems in the rat brain. Central injection of NT into the nucleus accumbens (NAcc) or peripheral administration of NT receptor agonists, reduces many of the behavioral effects of psychostimulants. However, the role of endogenous NT in the behavioral effects of psychostimulants (e.g. DA agonists and NMDA receptor antagonists) remains unclear. Using a NTR antagonist, SR142948A, the current studies were designed to examine the role of endogenous NT in DA receptor agonist- and NMDA receptor antagonist-induced disruption of prepulse inhibition of the acoustic startle response (PPI), locomotor hyperactivity and brain-region specific . c-fos mRNA expression. Adult male rats received a single i.p. injection of SR142948A or vehicle followed by . d-amphetamine, apomorphine or dizocilpine challenge. SR142948A had no effect on baseline PPI, but dose-dependently attenuated . d-amphetamine- and dizocilpine-induced PPI disruption and enhanced apomorphine-induced PPI disruption. SR142948A did not significantly affect either baseline locomotor activity or stimulant-induced hyperlocomotion. Systemic SR142948A administration prevented . c-fos mRNA induction in mesolimbic terminal fields (prefrontal cortex, lateral septum, NAcc, ventral subiculum) induced by all three psychostimulants implicating the VTA as the site for NT modulation of stimulant-induced PPI disruption. Further characterization of the NT system may be valuable to find clinical useful compounds for schizophrenia and drug addiction.

AB - The neuropeptide neurotensin (NT) is closely associated with dopaminergic and glutamatergic systems in the rat brain. Central injection of NT into the nucleus accumbens (NAcc) or peripheral administration of NT receptor agonists, reduces many of the behavioral effects of psychostimulants. However, the role of endogenous NT in the behavioral effects of psychostimulants (e.g. DA agonists and NMDA receptor antagonists) remains unclear. Using a NTR antagonist, SR142948A, the current studies were designed to examine the role of endogenous NT in DA receptor agonist- and NMDA receptor antagonist-induced disruption of prepulse inhibition of the acoustic startle response (PPI), locomotor hyperactivity and brain-region specific . c-fos mRNA expression. Adult male rats received a single i.p. injection of SR142948A or vehicle followed by . d-amphetamine, apomorphine or dizocilpine challenge. SR142948A had no effect on baseline PPI, but dose-dependently attenuated . d-amphetamine- and dizocilpine-induced PPI disruption and enhanced apomorphine-induced PPI disruption. SR142948A did not significantly affect either baseline locomotor activity or stimulant-induced hyperlocomotion. Systemic SR142948A administration prevented . c-fos mRNA induction in mesolimbic terminal fields (prefrontal cortex, lateral septum, NAcc, ventral subiculum) induced by all three psychostimulants implicating the VTA as the site for NT modulation of stimulant-induced PPI disruption. Further characterization of the NT system may be valuable to find clinical useful compounds for schizophrenia and drug addiction.

KW - Apomorphine

KW - C-fos

KW - D-amphetamine

KW - Dizocilpine

KW - Locomotion

KW - Neurotensin

KW - Prepulse inhibition

UR - http://www.scopus.com/inward/record.url?scp=84858000137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858000137&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2011.10.013

DO - 10.1016/j.schres.2011.10.013

M3 - Article

VL - 136

SP - 88

EP - 95

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -